For the first time in over twenty years, a new home-use treatment
for female hair loss is available. Lexington Intl, LLC, is excited
to announce they have received historic and groundbreaking FDA
Clearance for marketing for the HairMax LaserComb® Lux 9 to treat
female hair loss and promote hair growth.
Included as a key part of the submission was a
multi-center clinical study proving the efficacy and safety of the
HairMax.
“Hair loss amongst women is a growing concern”, says Dr. Matt
Leavitt, Medical Advisor to Lexington. “In the past, women had only
one FDA Approved drug ingredient to treat their hair loss. Now they
have a clinically proven viable alternative. Upon review of
Lexington’s extensive clinical studies on female hair loss, the FDA
has granted Clearance to this exciting new treatment option. I
believe the HairMax will be able to offer help to the millions of
women suffering from hair loss.”
The last hair loss treatment for women to be approved by the FDA was
minoxidil, which came to market for females in 1988. The HairMax is
now the first non-drug, home-use OTC medical device cleared to treat
the estimated 80 million men and women suffering from hereditary
hair loss.
Copyright stophairlossnow.co.uk